glp 1 agonist diabetes Evolution of GLP‐1 Receptor Agonists for Treatment GLP- 1 Agonist Therapy Center
Description
The piece was updated in November 2025
GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
The highest amount of weight lost from bariatric surgery participants was 250 pounds, and was 100 pounds for GLP-1 users
The menace within: bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases
Nor could they rule out contamination from some other intestinal peptides that might have stimulated insulin secretion instead of GLP-1
This led researchers to wonder if GIP agonists would even work in the population that needed them most
